
Alert: Rating Downgrade (3/7/25)-EyePoint Pharmaceuticals Inc (NASDAQ: EYPT).
Stock Rating Downgrade In the last week the Value Trend Rating for EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action EyePoint Pharmaceuticals Inc […]